Ticker
APVOCompany Name
APTEVO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 7.07M | $ 25.99M | $ 0 | $ 0 | -367.7% |
3/31/2025 | $ 2.68M | $ 15.6M | $ 0 | $ 0 | -582.91% |
12/31/2024 | $ 4.87M | $ 15.6M | $ 0 | $ 0 | -320.17% |
9/30/2024 | $ 5.72M | $ 15.07M | $ 0 | $ 0 | -263.44% |
6/30/2024 | $ 3.94M | $ 11.36M | $ 0 | $ 0 | -288.47% |
3/31/2024 | $ 4.18M | $ 7.87M | $ 0 | $ 0 | -188.17% |
12/31/2023 | $ 3.04M | $ 9.47M | $ -3.47M | $ 0 | -197.78% |
9/30/2023 | $ 3.36M | $ 9.78M | $ -3.97M | $ 0 | -172.78% |
6/30/2023 | $ 5.21M | $ 8.58M | $ -4.47M | $ 0 | -79.04% |
3/31/2023 | $ 12.33M | $ 8.54M | $ -4.97M | $ 0 | -28.96% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for APTEVO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 23K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 2.49M ]) / Market Cap [ $ 183.27M ]
(=) Shareholder Yield [ -1.37% ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |